American Well Corporation (AMWL)
NYSE: AMWL · Real-Time Price · USD
8.72
-0.24 (-2.68%)
Jul 28, 2025, 4:00 PM - Market closed

Company Description

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally.

The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as offers specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care for patients and members.

It also provides Carepoint devices, which transforms proprietary carts, peripherals, tablets, and TVs into digital access points in clinical settings.

In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, lactation counseling, and nutrition services.

Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services.

The company sells its products through field sales professionals, channel partners, and value-added resellers.

It serves providers, payers, and the government, as well as the higher education sector. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

American Well Corporation
American Well logo
CountryUnited States
Founded2006
IPO DateSep 17, 2020
IndustryHealth Information Services
SectorHealthcare
Employees877
CEOIdo Schoenberg

Contact Details

Address:
75 State Street, 26th Floor
Boston, Massachusetts 02109
United States
Phone617 204 3500
Websitebusiness.amwell.com

Stock Details

Ticker SymbolAMWL
ExchangeNYSE
Stock TypeCommon Stock
Share ClassClass A Shares
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$18.00
CIK Code0001393584
CUSIP Number03044L204
ISIN NumberUS03044L2043
SIC Code7389

Key Executives

NamePosition
Dr. Ido Schoenberg M.D.Chairman and Chief Executive Officer
Dr. Roy Schoenberg M.D., M.P.H.Executive Vice Chairman
Mark J. Hirschhorn CPAExecutive Vice President, Chief Operating Officer and Chief Financial Officer
Phyllis I. GotlibPresident of Amwell International
Paul Francis McNeiceVice President of Accounting
Dan ZamanskyChief Product and Technology Officer
Sue DooleyHead of Investor Relations
Anna NesterovaHead of Legal
Amber HoweChief People Officer
Dr. Cynthia Horner FAAFP, M.D.Chief Medical Officer and President of Amwell Medical Group

Latest SEC Filings

DateTypeTitle
Jul 1, 2025144Filing
Jun 17, 20258-KCurrent Report
Jun 2, 2025144Filing
May 15, 2025SCHEDULE 13G/AFiling
May 1, 2025144Filing
May 1, 202510-QQuarterly Report
May 1, 20258-KCurrent Report
Apr 23, 2025ARSFiling
Apr 23, 2025DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 23, 2025DEF 14AOther definitive proxy statements